A clinical trial to study the effect of the drug methylprednisolone injection when given at 2 different sites, in patients with Carpal Tunnel Syndrome
Phase 4
- Conditions
- Health Condition 1: null- Carpal Tunnel Syndrome
- Registration Number
- CTRI/2012/07/002813
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 218
Inclusion Criteria
patients coming to Neurology OPD with symptoms & signs of CTS of atleast 3 months with atleast one of the following electrophysiology features
Median motor distal Latency >4.5 ms
Difference in Median and Ulnar motor distal latency >0.5ms
Median sensory latency >3.4ms
Difference in Median and Ulnar sensory peak Latency >0.5ms
Exclusion Criteria
Severe CTS with thenar atrophy
18 years of age
Not willing to participate/give consent
Contraindications for corticosteroid injections (eg: skin infection at site)
Traumatic/Neoplastic origin of symptoms
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The CTS symptom severity score (SSS)change at 1 month after treatment. <br/ ><br>Timepoint: The CTS symptom severity score (SSS)change at 1 month after treatment. <br/ ><br>
- Secondary Outcome Measures
Name Time Method The CTS SSS changes at 3 month <br/ ><br>Direct treatment response at 1 month(physician) <br/ ><br>Improvement as perceived by patient <br/ ><br>Proportion of patients referred for surgery <br/ ><br>Adverse events <br/ ><br>Time taken for the procedure <br/ ><br>Pain perceived during the procedure <br/ ><br>Timepoint: at the time of procedure <br/ ><br>2 weeks,1 month,3 months after injection <br/ ><br>